Target intelligence / Profile preview

Pyruvate dehydrogenase kinase 1 mRNA (PDK1 mRNA)

Target
PDK1 mRNA
Molecular classification
Messenger RNA, Metabolic regulator
01

Overview

Pyruvate dehydrogenase kinase 1 (PDK1) mRNA is the messenger RNA transcript that encodes the PDK1 enzyme, a key metabolic gatekeeper located in the mitochondria. The encoded protein regulates the pyruvate dehydrogenase complex (PDC) by phosphorylating its E1 alpha subunit, thereby inhibiting the conversion of pyruvate into acetyl-CoA and suppressing mitochondrial oxidative respiration. This mechanism is a central component of the Warburg effect, where cancer cells preferentially utilize glycolysis even in the presence of oxygen to support rapid proliferation. PDK1 mRNA is frequently overexpressed in various malignancies, often under the control of hypoxia-inducible factor 1-alpha (HIF-1α), making it a prime target for therapeutic downregulation. Experimental strategies using siRNAs, shRNAs, or antisense oligonucleotides (ASOs) aim to degrade PDK1 mRNA to restore PDC activity, increase oxidative phosphorylation, and promote apoptosis in tumor cells. Additionally, the PDK1 pathway is a focus of research in metabolic diseases such as diabetes and heart failure, where modulating the glucose-to-oxidative metabolism balance can offer therapeutic benefits.

Other names
Pyruvate dehydrogenase kinase isoenzyme 1 mRNAPDK1 transcriptPDK1 messenger RNA3-phosphoinositide-dependent protein kinase 1 mRNA
02

Mechanism of action

RNA interference or antisense-mediated degradation of the PDK1 mRNA transcript, which reduces the translation of the PDK1 protein. This reduction leads to the reactivation of the pyruvate dehydrogenase complex, promoting the conversion of pyruvate to acetyl-CoA and shifting cellular metabolism from glycolysis to oxidative phosphorylation.

03

Biological functions

Regulation of glucose metabolismInhibition of pyruvate dehydrogenase complexWarburg effectCellular respiration
04

Disease associations

CancerDiabetesCardiovascular diseaseMetabolic syndrome
05

Safety considerations

Potential metabolic disruption in healthy tissuesOff-target effects of RNA-targeting agentsSystemic toxicity of delivery vehicles (e.g., lipid nanoparticles)
06

Interacting drugs

siRNA targeting PDK1

2 more in the full profile.

07

Biomarkers

PDK1 mRNA expression levelsLactate levelsHIF-1alpha expressionPyruvate dehydrogenase complex activity

Beyond the preview

Go deeper on Pyruvate dehydrogenase kinase 1 mRNA (PDK1 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pyruvate dehydrogenase kinase 1 mRNA (PDK1 mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call